| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. | SR. VP & CBO | Common Stock | 20,097 | $55,869 | $2.78 | 15 Dec 2025 | Direct |
| Celldex Therapeutics, Inc. | SR. VP & CBO | Incentive Stock Option (right to buy) | 0 | 15 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | 15 Dec 2025 | 4 | +$105,714 | 4 | SR. VP & CBO | 17 Dec 2025, 16:06 |
| CLDX | Celldex Therapeutics, Inc. | 05 Jun 2025 | 1 | $0 | 4 | SR. VP & CBO | 09 Jun 2025, 16:16 |
| CLDX | Celldex Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | SR. VP & CBO | 17 Jun 2024, 16:15 |
| CLDX | Celldex Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | SR. VP & CBO | 20 Jun 2023, 16:18 |
| CLDX | Celldex Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | SR. VP & CBO | 17 Jun 2022, 16:12 |
| CLDX | Celldex Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Sr. VP & CBO | 21 Jun 2021, 16:27 |